[ad_1]
A WHO new decision this week casts doubt on Chinese-made vaccines’ continued effectiveness for millions of people who have received them. According to the new recommendations, people who received Sinopharm/Sinovac twice could request a third dose, possibly of another vaccine. The move will reduce global supplies.
[ad_2]
